Table 3.
Opportunistic infections, malignities, and prognoses in our patients with HIV/AIDS
| n/% | |
|---|---|
| Opportunistic infections | |
| Tuberculosis | 19/16.5 |
| Shingles | 3/2.6 |
| PCP | 3/2.6 |
| Bacterial pneumonia | 3/2.6 |
| Lymphoma | 3/2.6 |
| Cryptosporidium-related diarrhea | 3/2.6 |
| Candidiasis | 3/2.6 |
| CMV disease | 3/2.6 |
| PML | 2/1.7 |
| Kaposi’s sarcoma | 2/1.7 |
| Cerebral toxoplasmosis | 1/0.9 |
| ITP | 1/0.9 |
| Malignities | |
| Intracranial | 3/2.6 |
| Pulmonary | 2/1.7 |
| Karposi’s sarcoma | 2/1.7 |
| Diffuse large B cell lymphoma | 1/0.9 |
| Burkitt’s lymphoma | 1/0.9 |
| Cervical dysplasia | 1/0.9 |
| Mortality | 13/11.3 |
CMV: cytomegalovirus; ITP: immune thrombocytopenia; PCP: Pneumocystis jirovecii (carinii) pneumonia; PML: progressive multifocal leukoencephalopathy
No data were available for 29 patients who failed to attend regular check-ups.